Use of Tachosil(®) as an adjuvant therapeutic option in neurotrophic keratopathy in order to prevent perforation

We present two cases of women who suffered from neurotrophic keratopathy (one of them had undergone penetrating keratoplasty) which had led to corneal thinning. Tachosil(®) was used as an adjuvant treatment after topical medication by itself failed in both cases. To our knowledge, there are no repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahhal-Ortuño, Miriam, Fernández-Santodomingo, Alex S, Molina-Pallete, Rodrigo D, Hurtado-Sarrió, Mercedes, Cisneros-Lanuza, Ángel L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611324/
https://www.ncbi.nlm.nih.gov/pubmed/31238463
http://dx.doi.org/10.4103/ijo.IJO_1573_18
Descripción
Sumario:We present two cases of women who suffered from neurotrophic keratopathy (one of them had undergone penetrating keratoplasty) which had led to corneal thinning. Tachosil(®) was used as an adjuvant treatment after topical medication by itself failed in both cases. To our knowledge, there are no reported cases of the use of Tachosil(®) in corneal grafts.

Ejemplares similares